Hyperperfusion on Magnetic Resonance Imaging in Acute Chemotherapy-Related Leukoencephalopathy

Abstract

Acute chemotherapy-related leukoencephalopathy can present similar to acute stroke with symptoms including aphasia, dysarthria, and hemiplegia. Differentiation based on clinical appearance is challenging, and physicians must distinguish between the 2 conditions rapidly to institute appropriate therapies. An 8-year-old male with acute lymphoblastic leukemia receiving chemotherapy, including intrathecal methotrexate, presented to our emergency center with 2 hours of expressive aphasia and flaccid right hemiplegia. Emergent magnetic resonance imaging (MRI) was obtained, demonstrating diffusion restriction within bilateral corona radiata and centrum semiovale. Magnetic resonance perfusion revealed mildly increased perfusion, a finding inconsistent with ischemic stroke and previously unreported in acute chemotherapy-related leukoencephalopathy without necrosis. This increased perfusion conclusively eliminated stroke from the clinical differential. Magnetic resonance perfusion imaging proved valuable to rapidly distinguish acute chemotherapy-related leukoencephalopathy from ischemia, and the evaluation of perfusion alterations in this disorder may provide further insight into the pathophysiology of this entity.

Keywords

magnetic resonance perfusion leukoencephalopathy chemotherapy magnetic resonance imaging methotrexate

Get full access to this article

View all access options for this article.

References

Baehring JM , Fulbright RK Delayed leukoencephalopathy with stroke-like presentation in chemotherapy recipients. J Neurol Neurosurg Psychiatry. 2008;79(5):535-539.

Mahoney DH Jr , Shuster JJ , Nitschke R. , et al. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy-a Pediatric Oncology Group study. J Clin Oncol. 1998;16(5):1712-1722.

Packer RJ , Zimmerman RA , Bilaniuk LT Magnetic resonance imaging in the evaluation of treatment-related central nervous system damage. Cancer. 1986;58(3):635-640.

Inaba H. , Khan RB , Laningham FH , Crews KR , Pui CH , Daw NC Clinical and radiological characteristics of methotrexate-induced acute encephalopathy in pediatric patients with cancer. Ann Oncol. 2008;19(1):178-184.

Raghavendra S. , Nair MD , Chemmanam T. , Krishnamoorthy T. , Radhakrishnan VV , Kuruvilla A. Disseminated necrotizing leukoencephalopathy following low-dose oral methotrexate. Eur J Neurol. 2007;14(3):309-314.

Grisold W. , Oberndorfer S. , Struhal W. Stroke and cancer: a review. Acta Neurol Scand. 2009;119(1):1-16.

Cestari DM , Weine DM , Panageas KS , Segal AZ , DeAngelis LM Stroke in patients with cancer: incidence and etiology. Neurology . 2004;62(11):2025-2030.

Haykin ME , Gorman M. , van Hoff J. , Fulbright RK , Baehring JM. Diffusion-weighted MRI correlates of subacute methotrexate-related neurotoxicity. J Neurooncol. 2006;76(2):153-157.

Eichler AF , Batchelor TT , Henson JW Diffusion and perfusion imaging in subacute neurotoxicity following high-dose intravenous methotrexate. Neuro Oncol. 2007 ;9(3):373-377.

10.

Drachtman RA , Cole PD , Golden CB , et al. Dextromethorphan is effective in the treatment of subacute methotrexate neurotoxicity. Pediatr Hematol Oncol. 2002;19(5):319-327.

11.

Hsu WH , Chu SJ , Tsai WC , Tsao YT Acute myeloid leukemia presenting as one-and-a-half syndrome. Am J Emerg Med. 2008;26(4):513e1-2.

12.

Olivot JM , Mlynash M. , Thijs VN , et al. Relationships between infarct growth, clinical outcome, and early recanalization in diffusion and perfusion imaging for understanding stroke evolution (DEFUSE). Stroke. 2008;39(8):2257-2263.

13.

Makiranta MJ , Lehtinen S. , Jauhiainen JP , Oikarinen JT , Pyhtinen J. , Tervonen O. MR perfusion, diffusion and BOLD imaging of methotrexate-exposed swine brain. J Magn Reson Imaging. 2002;15(5):511-519.

14.

Akiba T. , Okeda R. , Tajima T. Metabolites of 5-fluorouracil, alphafluoro-beta-alanine and fluoroacetic acid, directly injure myelinated fibers in tissue culture. Acta Neuropathol. 1996;92(1):8-13.